教育背景
2000-2005 郑州大学医学院临床医学系,医学学士
2005-2011 北京大学医学部/北京大学人民医院,内科学博士
工作经历
2011-2018 哈佛大学医学院/Dana-Farber癌症研究所(美国),博士后
2018-至今东北大学生命科学与健康学院,教授,博导
项目课题经历
论文、成果、著作等
代表性论文
1. Liu L, Michowski W, Kolodziejczyk A, Sicinski P. The cell cycle machinery in proliferation, pluripotency and differentiation of mammalian stem cells. Nat Cell Biol. 21(9):1060-1067 (2019).
2. Geng Y, Chick JM, Michowski W, Wang Y, Jecrois E, Sweeney K, Liu L, Han R, Ke N, Zagozdzon A, Sicinska E, Bronson RT, Gygi SP and Sicinski P. E-type cyclins are required for liver cancer progression through a kinase-Independent mechanism. Proc Natl Acad Sci U S A. 30;115(5):1015-1020 (2018).
3. Liu L, Michowski W, Inuzuka H, Shimizu K, Nihira NT, Chick JM, Li N, Geng Y, Meng AY, Ordureau A, Kolodziejczyk A, Ligon KL, Bronson RT, Polyak K, Harper JW, Gygi SP, Wei W, Sicinski P. G1 cyclins link proliferation, pluripotency and differentiation of embryonic stem cells. Nat Cell Biol. 19(3):177-188 (2017).
4. Li N, Fassl A, Chick J, Inuzuka H, Li X, Mansour MR, Liu L, Wang H, King B, Shaik S, Gutierrez A, Ordureau A, Otto T, Kreslavsky T, Baitsch L, Bury L, Meyer CA, Ke N, Mulry KA, Kluk MJ, Roy M, Kim S, Zhang X, Geng Y, Zagozdzon A, Jenkinson S, Gale RE, Linch DC, Zhao JJ, Mullighan CG, Harper JW, Aster JC, Aifantis I, von Boehmer H, Gygi SP, Wei W, Look AT, Sicinski P. Cyclin C is a haploinsufficient tumour suppressor. Nat Cell Biol. 16(11): 1080-91 (2014).
5. Liu L, Wang J, Du S, Tian J, Yang R, Wei L. RtE218G, a novel hepatitis B virus mutation with resistance to adefovir dipivoxil in patients with chronic hepatitis B. J Viral Hepatitis. 17 (S1): 66–72 (2010).
专利、著作版权等
声明:本站专家信息来源于各高校官网。